Efficacy of Enteral Iron Supplementation in Critical Illness

• Status: Completed
• Trial end date: 2008-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the efficacy of enteral iron supplementation for improving anemia, decreasing the risk of blood transfusion, and decreasing mortality in patients who are hospitalized in the intensive care unit. This study will also address any relationship between enteral iron supplementation and risk of infection.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Weill Medical College of Cornell University

Criteria

Inclusion Criteria:

• Age > 18 years

• Anemia (Hemoglobin < 13.0 g/dL)

• ≤ 72 hours from hospital admission

• Current tolerance of enteral medications

• Expected ICU LOS > 5 days

Exclusion Criteria:

• Active bleeding

• Chronic inflammatory disease

• End-stage renal disease

• Hematologic disorders

• Macrocytic anemia

• Current use of erythropoietin

• Pregnancy

• Prohibition of RBC transfusions

• Moribund state in which death is imminent

• Enrollment in another clinical trial